Immatics N.V logo

IMTX

Immatics N.V

$11.09

Earnings Summary

Revenue
$102.91Mn
Net Profits
$85.66Mn
Net Profit Margins
83.24%
PE Ratio
26.56

Highlights

Revenue:

Immatics N.V’s revenue jumped 1290.07% since last year same period to $102.91Mn in the Q1 2022. On a quarterly growth basis, Immatics N.V has generated 554.33% jump in its revenue since last 3-months.

Net Profits:

Immatics N.V’s net profit jumped 496.62% since last year same period to $85.66Mn in the Q1 2022. On a quarterly growth basis, Immatics N.V has generated 610.29% jump in its net profits since last 3-months.

Net Profit Margins:

Immatics N.V’s net profit margin jumped 128.53% since last year same period to 83.24% in the Q1 2022. On a quarterly growth basis, Immatics N.V has generated 177.99% jump in its net profit margins since last 3-months.

PE Ratio:

Immatics N.V’s price-to-earnings ratio after this Q1 2022 earnings stands at 26.56.

Earnings per share (EPS) Estimates

Earnings per share (EPS) estimates of the Immatics N.V post its latest quarter earnings

EPS Estimate Current Quarter
-0.15
EPS Estimate Current Year
-0.15

Highlights

EPS Estimate Current Quarter:

Immatics N.V’s earning per share (EPS) estimates for the current quarter stand at -0.15 - a -108.52% fall from last quarter’s estimates.

EPS Estimate Current Year:

Immatics N.V’s earning per share (EPS) estimates for the current year stand at -0.15.

Key Ratios

Key ratios of the Immatics N.V post its Q1 2022 earnings

Earning Per Share (EPS)
1.35
Return on Assets (ROA)
0.03
Return on Equity (ROE)
0.28
Dividend Per Share (DPS)
0

Highlights

Earning Per Share (EPS):

Immatics N.V’s earning per share (EPS) jumped 497.06% since last year same period to 1.35 in the Q1 2022. This indicates that the Immatics N.V has generated 497.06% annual rate of jump in its earning per share (EPS) in the last 4 quarters.

Return on Assets (ROA):

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Immatics N.V’s return on assets (ROA) stands at 0.03.

Earning Per Share (EPS):

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Immatics N.V’s return on equity (ROE) stands at 0.28.

Dividend Per Share (DPS):

Immatics N.V declared 0 dividend per share during the earnings announcement for Q1 2022.

Company Information

Immatics combines the discovery of true targets for cancer immunotherapies with the development of the right T cell receptors with the goal of enabling a robust and specific T cell response against these targets. This deep know-how is the foundation for our pipeline of Adoptive Cell Therapies and TCR Bispecifics as well as our partnerships with global leaders in the pharmaceutical industry. We are committed to delivering the power of T cells and to unlocking new avenues for patients in their fight against cancer.

Organisation
Immatics N.V
Headquarters
Tuebingen, Baden Wuerttemberg, Germany
Employees
2.02K
Industry
Health Technology